Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director | April 01, 2024 | April 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,900 |
Ending reported balance
After 2024-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-04-01 · Exercise / conversion · Acquired 296 · Balance 10,932 Row 2 · 2024-04-01 · Sale · Disposed 32 · Balance 10,900 F1: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2028-05-02 | Direct | 0 |
Reported balance
After 2024-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-04-01 · Exercise / conversion · Disposed 296 · Balance 0 F2: The option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: The option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2019 Filed May 6, 2019 22:10 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (right to buy) · Derivative | 4,569 | $0.00 Strike: $49.96 | $0.00 |
DisclosureSEC source: 0001104659-19-027224 · a4.xml · derivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,569 Underlying: Common Stock · 4,569 shares Expires 2029-05-02 F1 · derivative.exercise_date: The option vests and becomes exercisable on May 2, 2020, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 23:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,300 | $37.60 | $48,880.00 |
DisclosureSEC source: 0001104659-18-072861 · a4.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,112 Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries F Convertible Preferred Stock · Derivative | 53,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031861 · a4.xml · derivative · entry 6 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.exercise_date: Shares of Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.expiration_date: Shares of Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries E Convertible Preferred Stock · Derivative | 4,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031861 · a4.xml · derivative · entry 5 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F2 · derivative.exercise_date: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F2 · derivative.expiration_date: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries D Convertible Preferred Stock · Derivative | 46,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031861 · a4.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,026 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.exercise_date: Shares of Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.expiration_date: Shares of Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 8,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031861 · a4.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031861 · a4.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 7,026 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031861 · a4.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. Read SEC document |
| May 02, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (right to buy) · Derivative | 17,296 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031861 · a4.xml · derivative · entry 7 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,296 Underlying: Common Stock · 17,296 shares Expires 2028-05-02 F3 · derivative.exercise_date: The option vests and becomes exercisable on May 2, 2019, subject to the Reporting Person's continuous service to the Issuer through such date. The option was erroneously included on the Reporting Person's Form 3 filed on May 2, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.